Pharmaceutical Contract Manufacturing. Technology Transfer

This section is devoted to the Contract Manufacturing of Pharmaceuticals at the facilities of independent producers, who are fully compliant with technological processes and Quality Control in accordance with client requirements

Types of Contractors

  • Manufacturers, who specialize only in Contract Manufacturing
  • Manufacturers, who produce their own brands along with Contract Manufacturing

Types of Contract Services

  • Full-cycle manufacturing
  • Performing only some of the manufacturing operations (ex. packaging)
scientist

Canon Medical establishes a joint company with ACT Genomics

Canon Medical System Corporation completed the acquisition of the majority shares of ACTmed, a joint venture company established with ACT Genomics, a Taiwanese molecular diagnostic company.
nacimbio

Nacimbio completed Phase I clinical trials of the rotavirus vaccine

Nacimbio has completed the first phase of clinical trials of the rotavirus vaccine. The new drug will be packaged in Russia in 2020 already, while the full production cycle will be launched in 2026.
pharmstandard

Gilead localizes the production of hepatitis C and HIV drugs in Russia

According to the agreement Pharmstandard production facilities will manufacture Sovaldi® for the treatment of chronic hepatitis C and Truvada® for the treatment of HIV.
stem cells

Takara Bio receives a manufacturing license from Swedish Medical Product Agency

Takara Bio announced that the Medical Products Agency granted a manufacturing license for derivation and banking of human embryonic stem (hES) cells to be produced under GMP conditions.
takeda

Takeda launches production of the Ixazomib in Yaroslavl

The global pharmaceutical company Takeda announces the opening of a production site at its plant in Yaroslavl for manufacturing Ixazomib, an innovative drug for patients with multiple myeloma.
pik-pharma

PIK-PHARMA localized full-cycle manufacturing of Magnerot

PIK-PHARMA has successfully localized full-cycle manufacturing of Magnerot, a popular drug of WÖRWAG Pharma GmbH from Germany, at the facilities of PIK-PHARMA LEK site.
stem cells

Israeli biotech receives financing to develop precision-medicine technology

NewStem, a Jerusalem-based biotech with a novel precision-medicine technology that can increase chemotherapy's effectiveness, announced a $4 million financing.
pharma-manufacturing

Belarus will help to organize pharma manufacturing in Tajikistan

By the end of this year, Belarus and Tajikistan may elaborate a roadmap to establish joint ventures in the pharmaceutical industry, announced Oleg Ivanov, the Ambassador of Belarus in Tajikistan and Afghanistan.
novartis

French CDMO will manufacture innovative cancer treatments for Novartis

Novartis signed an agreement with CELLforCURE to produce innovative cancer treatments known as CAR-T therapies (chimeric antigen receptor T-cells) at the bioproduction site based in Les Ulis (Essonne).

Actual

Contact Manufacturing Companies